These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques. Egan MA; Chong SY; Hagen M; Megati S; Schadeck EB; Piacente P; Ma BJ; Montefiori DC; Haynes BF; Israel ZR; Eldridge JH; Staats HF Vaccine; 2004 Sep; 22(27-28):3774-88. PubMed ID: 15315859 [TBL] [Abstract][Full Text] [Related]
26. Bioluminescent immunoassay using a fusion protein of protein A and the photoprotein aequorin. Zenno S; Inouye S Biochem Biophys Res Commun; 1990 Aug; 171(1):169-74. PubMed ID: 2203343 [TBL] [Abstract][Full Text] [Related]
27. Impaired mucosal immune responses in interleukin 4-targeted mice. Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021 [TBL] [Abstract][Full Text] [Related]
28. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant. Vajdy M; Lycke N Immunology; 1993 Oct; 80(2):197-203. PubMed ID: 7505255 [TBL] [Abstract][Full Text] [Related]
29. Cholera toxin as a mucosal adjuvant: III. Antibody responses to nontarget dietary antigens are not increased. Nedrud JG; Sigmund N Reg Immunol; 1990-1991; 3(5):217-22. PubMed ID: 1966580 [TBL] [Abstract][Full Text] [Related]
30. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen. Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444 [TBL] [Abstract][Full Text] [Related]
31. Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunization. Vajdy M; Lycke N Immunology; 1995 Nov; 86(3):336-42. PubMed ID: 8550068 [TBL] [Abstract][Full Text] [Related]
32. Enhancement of nasal clearance of nontypeable Haemophilus influenzae by oral immunization with outer membrane proteins. Suzuki M; Kurono Y; Kodama S; Shigemi H; Mogi G Acta Otolaryngol; 1998 Nov; 118(6):864-9. PubMed ID: 9870635 [TBL] [Abstract][Full Text] [Related]
33. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity. Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451 [TBL] [Abstract][Full Text] [Related]
34. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response. Chen KS; Strober W Eur J Immunol; 1990 Feb; 20(2):433-6. PubMed ID: 2311649 [TBL] [Abstract][Full Text] [Related]
35. Mucosal immunogenicity of plant lectins in mice. Lavelle EC; Grant G; Pusztai A; Pfüller U; O'Hagan DT Immunology; 2000 Jan; 99(1):30-7. PubMed ID: 10651938 [TBL] [Abstract][Full Text] [Related]
36. Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice. Howe SE; Konjufca VH PLoS One; 2015; 10(2):e0118067. PubMed ID: 25710518 [TBL] [Abstract][Full Text] [Related]
37. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine. Abd Alla MD; White GL; Rogers TB; Cary ME; Carey DW; Ravdin JI Infect Immun; 2007 Aug; 75(8):3812-22. PubMed ID: 17526742 [TBL] [Abstract][Full Text] [Related]
39. Development of a novel in vitro assay (ALS assay) for evaluation of vaccine-induced antibody secretion from circulating mucosal lymphocytes. Chang HS; Sack DA Clin Diagn Lab Immunol; 2001 May; 8(3):482-8. PubMed ID: 11329444 [TBL] [Abstract][Full Text] [Related]
40. Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance. Kjerrulf M; Grdic D; Ekman L; Schön K; Vajdy M; Lycke NY Immunology; 1997 Sep; 92(1):60-8. PubMed ID: 9370925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]